Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim PK/PD study in Chinese adults with immune thrombocytopenia
ChiCTR-OPC-15007012Phase 2Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of romiplostim in immune thrombocytopenia (ITP) (3 arms), sponsored by Institute of Hematology and Blood Diseases Hospital. Primary endpoints: Safety evaluation, Pharmacodynamics and 1 more. Started Jun 2015; status: recruiting.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR-OPC-15007012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15007012.